ANCHOR THERAPEUTICS INC has a total of 31 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are NORTHSTAR BIOLOG PTY LTD, PANTHERYX INC and MADAUS AG KOELN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | China | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | United States | 2 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mcmurry Thomas J | 23 |
#2 | Kuliopulos Athan | 15 |
#3 | Looby Richard J | 10 |
#4 | Janz Jay | 7 |
#5 | Tchernychev Boris | 6 |
#6 | Covic Lidija | 6 |
#7 | Athan Kuliopulos | 4 |
#8 | Gross Brett | 3 |
#9 | Thomas J Mcmurry | 2 |
#10 | Boris Tchernychev | 2 |
Publication | Filing date | Title |
---|---|---|
WO2015010045A1 | Apj receptor compounds | |
CN104254540A | APJ receptor compounds | |
WO2010053546A2 | Crf1 receptor compounds | |
WO2010053548A2 | Pthr1 receptor compounds | |
WO2010053547A2 | Cxcr5 receptor compounds | |
BRPI0921815A2 | apj receptor compounds | |
CA2742509A1 | Cxcr4 receptor compounds |